Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 10 | -7 | 1 | 4 | -11 |
| Other Working Capital | -13 | -29 | -75 | -14 | 325 |
| Other Operating Activity | -162 | -163 | -159 | -164 | -226 |
| Operating Cash Flow | $-165 | $-200 | $-233 | $-173 | $89 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 47 | N/A |
| Common Stock Issued | 1 | 0 | 187 | 565 | -16 |
| Other Financing Activity | 78 | 40 | -127 | 0 | -58 |
| Financing Cash Flow | $79 | $40 | $61 | $612 | $-74 |
| Beginning Cash Position | 122 | 284 | 456 | 17 | 2 |
| End Cash Position | 37 | 122 | 284 | 456 | 17 |
| Net Cash Flow | $-86 | $-161 | $-172 | $438 | $15 |
| Free Cash Flow | |||||
| Operating Cash Flow | -165 | -200 | -233 | -173 | 89 |
| Free Cash Flow | -165 | -200 | -233 | -173 | 89 |